Markets › LSE › FARN.L

Faron Pharmaceuticals Oy

LSE:FARN.LHealthcareFTSE:AXX

£0.3500+0.00%Delayed 15 minIn session · ≈ AED 1.71 · Market cap $90.3M · Next earnings Fri 19 Mar

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	916.5%	−726.3%	250.3%	204.1%	0.3%	147.3%	147.3%	+0.0 pts
Return on assets	−202.5%	−160.8%	−254.9%	−302.8%	−0.2%	−158.7%	−158.7%	+0.0 pts
Return on capital employed	−893.5%	−351.6%	−3,428.3%	596.2%	−0.8%	1,190.8%	—	—
Debt / equity	−1.7×	1.2×	−1.2×	−0.9×	−1.2×	−1.3×	−1.3×	+0.0%
Debt / assets	38.5%	26.9%	117.7%	128.3%	96.7%	143.7%	—	—
Interest coverage	−42.8×	−89.8×	−19.6×	0.0×	−4.8×	−2.1×	—	—
Current ratio	1.1×	1.7×	0.9×	0.6×	1.1×	0.8×	0.8×	+0.0%
Quick ratio	1.1×	1.7×	0.9×	0.6×	1.1×	0.8×	—	—
Cash ratio	0.6×	1.0×	0.7×	0.5×	0.9×	0.7×	0.7×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	—	—	—	—	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.